Ruti Aga's Six-Year Ban: The Error Was Never the Steroid, It Was the Prescription Pad

Six years. For Ruti Aga that number arrives in two pieces — two years for the substance, four for the paperwork. I have an old habit at the desk: when a sanction lands, I read the arithmetic before I read the statement. Two plus four equals six tells you most of what you need. The panel accepted the presence violation but not the intent, which left room to reduce the period — and then the tampering charge took that room away. The blow that ended this career was not a banned substance. It was a prescription pad.

That line is painful, but it does not need to become sentiment. It is technical, and it should stay technical.

Aga is 32. She won the 2026 Tokyo Marathon in 2:20:40, finished second at Berlin 2026 in 2:18:34, and has three second-place finishes at World Marathon Majors. She has zero global championship medals. That fact is worth recording because this case is being sold as a story about a medal being stripped, and nothing of the kind happened.

In March she won a half marathon in China. The mark is not disclosed in the original report — the first signal that the story is not about sport. An in-competition sample returned methylprednisolone. Her explanation was a knee injury. The paperwork for that treatment collapsed in three separate places: the clinic named on the prescription did not exist; the person who wrote it was a family member with no medical registration; and that person claimed to have used 'an old prescription pad from a former workplace,' which the clinic explicitly disowned. Three independent verification failures. Not one coincidence.

That Tokyo race is still logged in my split database, and it is the strangest part of this case — an athlete whose run I once measured with a stopwatch had the last year of her career decided not by a timer, but by a piece of paper.

Here is the point where nearly every media report has gone wrong, and the error is not small. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, class S9 on the WADA Prohibited List — and S9 is prohibited in-competition only, by injection, oral or rectal route. One word changes the entire defence architecture. Steroid implies a performance-enhancing substance, out of competition and in, always. Glucocorticoid implies an anti-inflammatory that becomes a violation only inside the testing window. A therapeutic knee injection out of competition is entirely legal. It becomes a violation only if residues are present on race day. The question was never whether the drug was taken. The question was which route, and how many days before the start.

That is what makes this case so strange. Aga had a legitimate defence available, and the forged prescription destroyed it. With real medical records — injection date, route, the doctor's registration, the clinic's invoice — this could have landed in the no-significant-fault category, where the Code leaves room for a reprimand or a heavily reduced period. The four-year tampering charge would never have been built. In the best case, with a proper TUE or correct washout timing, there would have been no case at all.

This is where an old habit returns. In 2026 I wrote a prediction that Germany would not survive their group, on one sheet, with three hard reasons — and the tactics room was quiet. The point was never that I knew something others didn't. The point was that I wrote the claim down early and cleanly enough that the reporting could embarrass it. Aga's case ran the other way. She wrote a claim down too. It was forged. And a forged claim never gets proven wrong; it only gets caught.

The third point, and the most ignored — the root of this case sits in medical governance, not in the substance. A 32-year-old world-class marathoner with no credentialed team physician, no TUE infrastructure, and a chronic knee problem handled by a relative. That is not carelessness. It is the direct output of the economy elite road runners live inside. In the marathon, appearance fees are the real income. If the knee hurts and the race is six weeks out, the pressure is obvious — run, inject, show up. The football vocabulary is easy to borrow here: this is contract season, and the player has to look fit. The disanalogy matters, though. In football a club medical staff owns the paperwork. In road racing there is often no owner at all.

Which is where I get uncomfortable, and hiding it would be dishonest.

Six years for a substance with no proven endurance benefit. A glucocorticoid reduces pain and swelling; it does not build muscle. Compare that with cases where actual anabolic steroids or EPO are caught and four years is handed down. The six here exists because the penalty landed on the paper, not the drug. I will not argue a forged prescription deserves leniency — it does not. I am arguing that the day 'steroid' and 'glucocorticoid' get folded into the same headline, this sanction starts to look disproportionate, and the argument that the AIU is harsher on African road runners advances without a factual base. That argument should be had — on the correct footing.

So here is my falsifier, written down rather than remembered later. This reading collapses if any one of three things proves true. One: a CAS appeal surfaces genuine medical records and shows the prescription was merely late, not fabricated. Two: it emerges the 'family member' was in fact a registered practitioner and the AIU did not verify registration properly. Three: it turns out the panel never weighed S9's in-competition-only provision when assembling the sanction. Any one of those, and the whole framework falls.

One more thing needs saying plainly. China's label-race circuit is becoming the most scrutinised zone in the sport. Large appearance-fee budgets, deep East African elite fields, and AIU testing are now colliding in the same races. Pune taught me that a youth games and a dying franchise can share a week. Same structure here: the income economy and the testing economy are running in the same race. I have learned to read the scoreboard and the balance sheet as one text — and in this case the scoreboard has no time written on it at all.

The ban runs from 10 September, and six years on, Aga will be 38. Ethiopian women's marathon depth is such that a 2:18 performer is not automatically selectable for her own national team. The sanction is technically six years and functionally a lifetime.

The question ahead is not whether Aga returns. It is how many of the AIU's next dozen statements will have the substance in a supporting role and the documents in the lead. The day that ratio shifts, we will also have to decide who pays for a credentialed team physician in road racing. Until there is an answer, knee injections will keep happening in the dark — and so will the prescriptions.